Profiel
Dr. Mitchell S.
Seyedin is Executive Chairman at ISTO Technologies, Inc. He is on the Board of Directors at Biosurface Engineering Technologies, Inc.
Dr. Seyedin was previously employed as Vice President-Research & Development by Metra Biosystems, Inc., a Director-Research & Development by Collagen Corp., and President & Chief Executive Officer by CBYON, Inc. He also served on the board at Orquest, Inc.
He received his undergraduate degree from the University of Wisconsin and a doctorate degree from the University of South Carolina.
Eerdere bekende functies van Mitchell S. Seyedin
| Bedrijven | Functie | Einde |
|---|---|---|
Orquest, Inc.
 Orquest, Inc. Medical SpecialtiesHealth Technology Orquest, Inc. developed and manufactured bone graft materials. Its technology HEALOS Bone Graft Material, was designed and developed to reduce the time and pain associated with standard bone graft harvesting. Orquest was located in Mountain View, CA. | Oprichter | 01-01-2003 |
Biosurface Engineering Technologies, Inc.
 Biosurface Engineering Technologies, Inc. Medical SpecialtiesHealth Technology Biosurface Engineering Technologies, Inc. was a holding company, which engaged in the development of proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair. It offered amplex and soft tissue augmentation services. The company was founded by Thomas G. Roueche, Paul O. Zamora, William G. Mavity, and Linda M. Finn in 2001 and was headquartered in Rockville, MD. | Directeur/Bestuurslid | - |
| Collagen Corp. | Hoofd Techniek/Wetenschap/O&O | - |
| CBYON, Inc. | Algemeen Directeur | - |
Metra Biosystems, Inc.
 Metra Biosystems, Inc. Medical SpecialtiesHealth Technology Metra Biosystems Inc was a leader in developing and commercializing diagnostic products for the detection and management of metabolic bone diseases and disorders. The company's strategy is to offer a portfolio of tests that will provide physicians with comprehensive clinical information regarding the metabolism of bone and other connective tissues | Oprichter | - |
Opleiding van Mitchell S. Seyedin
| University of Wisconsin | Undergraduate Degree |
| University of South Carolina | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Metra Biosystems, Inc.
Metra Biosystems, Inc. Medical SpecialtiesHealth Technology Metra Biosystems Inc was a leader in developing and commercializing diagnostic products for the detection and management of metabolic bone diseases and disorders. The company's strategy is to offer a portfolio of tests that will provide physicians with comprehensive clinical information regarding the metabolism of bone and other connective tissues | Health Technology |
Biosurface Engineering Technologies, Inc.
Biosurface Engineering Technologies, Inc. Medical SpecialtiesHealth Technology Biosurface Engineering Technologies, Inc. was a holding company, which engaged in the development of proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair. It offered amplex and soft tissue augmentation services. The company was founded by Thomas G. Roueche, Paul O. Zamora, William G. Mavity, and Linda M. Finn in 2001 and was headquartered in Rockville, MD. | Health Technology |
| Collagen Corp. | Health Technology |
Orquest, Inc.
Orquest, Inc. Medical SpecialtiesHealth Technology Orquest, Inc. developed and manufactured bone graft materials. Its technology HEALOS Bone Graft Material, was designed and developed to reduce the time and pain associated with standard bone graft harvesting. Orquest was located in Mountain View, CA. | Health Technology |
ISTO Technologies, Inc.
 ISTO Technologies, Inc. Medical SpecialtiesHealth Technology ISTO Technologies, Inc. develops and markets clinical solutions for spinal therapy, sports medicine, and trauma. It develops biologic products to rebuild bone, and heal degenerated or damaged cartilage. The company was founded by Joseph Feder and Scott Gill in 1997 and is headquartered in St. Louis, MO. | Health Technology |
| CBYON, Inc. |
